Abbott Laboratories
NYSE: ABT
Stock price
84.38 USD
(+Infinity%) NaN day
Medical - Devices
Financials
all figures in US$ Millions except per share data
Sections:
Periods:
View:
Format:
Actual
10 year cagr
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share 
Earnings per share = Net Income / Number of Shares Outstanding
2.9
0.9
0.3
1.3
2.1
2.5
3.9
3.9
3.3
7.6
3.7
2.4%
02Free cash flow per share
1.2
1.4
2.5
2.8
2.5
3.2
4.8
4.4
2.9
3.6
4.2
13.1%
03Dividends per share
1
1
1.1
1.1
1.3
1.4
1.8
1.9
2
2.2
2.4
9.4%
04Dividends payout, %
32.6%
1.1%
3.9%
83.4%
61.6%
57%
45.3%
47.7%
62.1%
28.6%
63.1%
6.8%
PROFIT AND LOSS STATEMENT
05Revenue
20,405
20,853
27,390
30,578
31,904
34,608
43,075
43,653
40,109
41,950
44,328
8.1%
06% Change
-
2.2%
31.4%
11.6%
4.3%
8.5%
24.5%
1.3%
(8.1)%
4.6%
5.7%
11.1%
07Cost of revenue
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
08Gross profit
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
09% Margin
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
10Operating expenses
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
11% of Revenue
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
12Operating Income
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
13Income tax expense
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
14Net Income
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
15% Margin
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
16Shares Outstanding
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
17EPS Basic
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
18EPS Diluted
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
19EBITDA
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
20Net Interest Income (expense)
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
21Net Debt / EBITDA
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
BALANCE SHEET
ASSETS
Current Assets
Non-Current Assets
Total Assets
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
LIABILITIES
Current Liabilities
Non-Current Liabilities
SHAREHOLDERS` EQUITY
22Total Liabilities and shareholders' Equity
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
23Total Investments
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
24Total Debt
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
25Net Debt
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
26Net income (loss)
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
27Net cash flows from operating activities
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
CASH FLOWS FROM INVESTING ACTIVITIES
28Net cash flows from investing activities
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
CASH FLOWS FROM FINANCING ACTIVITIES
29Net cash flows from financing activities
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
30Increase (decrease) in cash and cash equivalents
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
31Cash and equivalents, ending balance
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
32Free Cash Flow to the Firm (FCFF)
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in
Sign in